EMBO Molecular Medicine, 1757-4684

Journal

More filtering options
  1. Plasma fibronectin deficiency impedes atherosclerosis progression and fibrous cap formation

    Ina Rohwedder, Eloi Montanez, Karsten Beckmann, Eva Bengtsson, Pontus Dunér, Jan Nilsson, Oliver Soehnlein & Reinhard Faessler, 2012, In: EMBO Molecular Medicine. 4, 7, p. 564-576

    Research output: Contribution to journalArticle

  2. Alternative oxidase-mediated respiration prevents lethal mitochondrial cardiomyopathy

    Jayasimman Rajendran, Janne Purhonen, Saara Tegelberg, Olli Pekka Smolander, Matthias Mörgelin, Jan Rozman, Valerie Gailus-Durner, Helmut Fuchs, Martin Hrabe de Angelis, Petri Auvinen, Eero Mervaala, Howard T. Jacobs, Marten Szibor, Vineta Fellman & Jukka Kallijärvi, 2018, In: EMBO Molecular Medicine. 2018, e9456.

    Research output: Contribution to journalArticle

  3. Cerebrospinal fluid and plasma biomarker trajectories with increasing amyloid deposition in Alzheimer's disease

    Sebastian Palmqvist, Philip S. Insel, Erik Stomrud, Shorena Janelidze, Henrik Zetterberg, Britta Brix, Udo Eichenlaub, Jeffrey L. Dage, Xiyun Chai, Kaj Blennow, Niklas Mattsson & Oskar Hansson, 2019 Dec 1, In: EMBO Molecular Medicine. 11, 12, e11170.

    Research output: Contribution to journalArticle

  4. Amyloid blood biomarker detects Alzheimer's disease

    Andreas Nabers, Laura Perna, Julia Lange, Ute Mons, Jonas Schartner, Jörn Güldenhaupt, Kai Uwe Saum, Shorena Janelidze, Bernd Holleczek, Dan Rujescu, Oskar Hansson, Klaus Gerwert & Hermann Brenner, 2018, In: EMBO Molecular Medicine. 10, 5, e8763.

    Research output: Contribution to journalArticle

  5. Anti-tumor effects of PIM/PI3K/mTOR triple kinase inhibitor IBL-302 in neuroblastoma

    Sofie Mohlin, Karin Hansson, Katarzyna Radke, Sonia Martinez, Carmen Blanco-Apiricio, Cristian Garcia-Ruiz, Charlotte Welinder, Javanshir Esfandyari, Michael O'Neill, Joaquin Pastor, Kristoffer von Stedingk & Daniel Bexell, 2019 Aug 1, In: EMBO Molecular Medicine. 11, 8, e10058.

    Research output: Contribution to journalArticle

  6. Soluble P-tau217 reflects amyloid and tau pathology and mediates the association of amyloid with tau

    Niklas Mattsson-Carlgren, Shorena Janelidze, Randall J. Bateman, Ruben Smith, Erik Stomrud, Geidy E. Serrano, Eric M. Reiman, Sebastian Palmqvist, Jeffrey L. Dage, Thomas G. Beach & Oskar Hansson, 2021 May 1, In: EMBO Molecular Medicine.

    Research output: Contribution to journalArticle

  7. Cerebrospinal fluid tau, neurogranin, and neurofilament light in Alzheimer's disease

    Niklas Mattsson, Philip S. Insel, Sebastian Palmqvist, Erik Portelius, Henrik Zetterberg, Michael Weiner, Kaj Blennow & Oskar Hansson, 2016 Oct 1, In: EMBO Molecular Medicine. 8, 10, p. 1184-1196 13 p.

    Research output: Contribution to journalArticle

  8. 18F-AV-1451 and CSF T-tau and P-tau as biomarkers in Alzheimer's disease

    Niklas Mattsson, Michael Schöll, Olof Strandberg, Ruben Smith, Sebastian Palmqvist, Philip S. Insel, Douglas Hägerström, Tomas Ohlsson, Henrik Zetterberg, Jonas Jögi, Kaj Blennow & Oskar Hansson, 2017, In: EMBO Molecular Medicine. 9, p. 1212-1223

    Research output: Contribution to journalArticle

  9. Streptococcus pneumoniae evades human dendritic cell surveillance by pneumolysin expression

    Marie Littmann, Barbara Albiger, Anne Frentzen, Staffan Normark, Birgitta Henriques-Normark & Laura Plant, 2009, In: EMBO Molecular Medicine. 1, 4, p. 211-222

    Research output: Contribution to journalArticle

Previous 1 2 Next